Changing Management of Hematological Malignancies With COVID-19: Statement and Recommendations of the Lebanese Society of Hematology and Blood Transfusion

COVID-19 caused by SARS-Cov-2 is a devastating infection in patients with hematological malignancies. In 2018, the Lebanese Society of Hematology and Blood Transfusion (LSHBT) updated the guidelines for the management of hematological malignancies in Lebanon. In 2019, it was followed by a second upd...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Ahmad Ibrahim, Peter Noun, Charbel Khalil, Ali Taher
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Frontiers Media S.A. 2021-03-01
סדרה:	Frontiers in Oncology
נושאים:	SARS-Cov-2 infection LSHBT hematological malignancies myeloid lymphoid
גישה מקוונת:	https://www.frontiersin.org/articles/10.3389/fonc.2021.564383/full
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!